Chemoinformaics analysis of alpha-D-Glucose 1,6-bisphosphate
| Molecular Weight | 340.114 | nRot | 5 |
| Heavy Atom Molecular Weight | 326.002 | nRig | 10 |
| Exact Molecular Weight | 339.996 | nRing | 1 |
| Solubility: LogS | -0.039 | nHRing | 1 |
| Solubility: LogP | -3.352 | No. of Aliphatic Rings | 1 |
| Acid Count | 4 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 0 |
| nHA | 8 | APOL | 36.2391 |
| nHD | 7 | BPOL | 36.6689 |
| QED | 0.326 |
| Synth | 6.012 |
| Natural Product Likeliness | 1.245 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.028 |
| HIA | 0.962 |
| CACO-2 | -6.29 |
| MDCK | 0.000557093 |
| BBB | 0.411 |
| PPB | 0.0791466 |
| VDSS | 0.254 |
| FU | 0.74798 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.018 |
| CYP2c19-inh | 0.035 |
| CYP2c19-sub | 0.031 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.86 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.09 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.001 |
| CL | 1.406 |
| T12 | 0.865 |
| hERG | 0.011 |
| Ames | 0.039 |
| ROA | 0.001 |
| SkinSen | 0.15 |
| Carcinogencity | 0.033 |
| EI | 0.036 |
| Respiratory | 0.157 |
| NR-Aromatase | 0 |
| Antiviral | No |
| Prediction | 0.769709 |